Tag:
myeloid leukemia
Latest Headlines
Latest Headlines
Kedem adapting Novartis' Gleevec to dissolve under tongue
Kedem Pharmaceuticals has begun developing a child-friendly version of Novartis' ( $NVS ) cancer blockbuster Gleevec that would have a decent taste and dissolve under the tongue. In announcing...
It's final: Tasigna in, Sprycel out in NICE guidelines
The National Institute for Health and Clinical Excellence has struck again. Despite two appeals of its draft recommendations, the agency let in only one new drug for chronic myeloid leukemia.
Pfizer seeks 2nd chance for cancer drug Mylotarg
Pfizer ( $PFE ) has potentially found a second life for its controversial blood cancer drug Mylotarg, Bloomberg News reports. From 2000 to 2010, the drug was used to treat patients with acute myeloid
